The Manufacturers Life Insurance Company Sells 3,563 Shares of The Ensign Group, Inc. $ENSG

The Manufacturers Life Insurance Company reduced its stake in The Ensign Group, Inc. (NASDAQ:ENSG) by 6.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 53,684 shares of the company’s stock after selling 3,563 shares during the period. The Manufacturers Life Insurance Company owned approximately 0.09% of The Ensign Group worth $10,817,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the stock. Quantinno Capital Management LP raised its stake in The Ensign Group by 137.2% in the first quarter. Quantinno Capital Management LP now owns 23,683 shares of the company’s stock valued at $4,772,000 after purchasing an additional 13,698 shares in the last quarter. Lazard Asset Management LLC grew its stake in The Ensign Group by 9.0% during the first quarter. Lazard Asset Management LLC now owns 28,754 shares of the company’s stock worth $5,794,000 after buying an additional 2,374 shares in the last quarter. Gateway Wealth Partners LLC bought a new position in The Ensign Group in the 1st quarter valued at about $695,000. Entropy Technologies LP raised its position in shares of The Ensign Group by 30.0% in the 1st quarter. Entropy Technologies LP now owns 13,372 shares of the company’s stock valued at $2,694,000 after buying an additional 3,085 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in shares of The Ensign Group by 28.0% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 58,056 shares of the company’s stock worth $11,698,000 after acquiring an additional 12,717 shares during the period. Institutional investors and hedge funds own 96.12% of the company’s stock.

The Ensign Group Stock Performance

Shares of The Ensign Group stock opened at $177.23 on Tuesday. The stock has a market cap of $10.33 billion, a price-to-earnings ratio of 27.78, a P/E/G ratio of 1.71 and a beta of 0.69. The Ensign Group, Inc. has a twelve month low of $141.58 and a twelve month high of $218.00. The company’s fifty day moving average is $165.92 and its 200 day moving average is $184.01. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 0.06.

The Ensign Group (NASDAQ:ENSG) last announced its earnings results on Monday, July 27th. The company reported $1.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.80 by $0.12. The Ensign Group had a return on equity of 16.75% and a net margin of 6.90%.The business had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.44 billion. During the same period last year, the company earned $1.59 EPS. The Ensign Group’s revenue for the quarter was up 16.7% compared to the same quarter last year. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. Sell-side analysts forecast that The Ensign Group, Inc. will post 6.93 EPS for the current year.

The Ensign Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 31st. Investors of record on Tuesday, June 30th were paid a $0.065 dividend. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.1%. The ex-dividend date of this dividend was Tuesday, June 30th. The Ensign Group’s payout ratio is currently 4.08%.

Insider Activity at The Ensign Group

In other The Ensign Group news, Director John O. Agwunobi sold 392 shares of the stock in a transaction that occurred on Monday, July 20th. The shares were sold at an average price of $171.06, for a total transaction of $67,055.52. Following the completion of the sale, the director owned 9,503 shares of the company’s stock, valued at approximately $1,625,583.18. This represents a 3.96% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Barry M. Smith sold 700 shares of the firm’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $164.28, for a total transaction of $114,996.00. Following the transaction, the director owned 21,352 shares of the company’s stock, valued at approximately $3,507,706.56. The trade was a 3.17% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 4.00% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently issued reports on the stock. Weiss Ratings lowered shares of The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, June 16th. Truist Financial raised their target price on The Ensign Group from $202.00 to $207.00 and gave the company a “hold” rating in a report on Thursday, July 30th. Zacks Research lowered The Ensign Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Wall Street Zen downgraded The Ensign Group from a “buy” rating to a “hold” rating in a research report on Saturday, July 25th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $228.00 price objective on shares of The Ensign Group in a research note on Tuesday, July 28th. Four research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $216.25.

The Ensign Group Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.